Publications

Filter by type:

Timothy O’Donnell, Elizabeth L. Christie, Arun Ahuja, Jacqueline Buros, B. Arman Aksoy, David D. L. Bowtell, Alexandra Snyder, Jeff Hammerbacher. Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer. BMC Cancer, 2018.

Samuel L. Brilleman, Michael J. Crowther, Margarita Moreno-Betancur, Jacqueline Buros Novik, James Dunyak, Nidal Al-Huniti, Robert Fox, Jeff Hammerbacher, Rory Wolfe. Joint longitudinal and time-to-event models for multilevel hierarchical data. Statistical Methods in Medical Research, 2018.

Martin Henner Voss, Jacqueline Buros Novik, Matthew David Hellmann, Mark Ball, A. Ari Hakimi, Diana Miao, Claire Margolis, Christine Horak, Megan Wind-Rotolo, Guillermo De Velasco, Nizar M. Tannir, Pheroze Tamboli, Leonard Joseph Appleman, Kimryn Rathmell, James J Hsieh, Mohamad Allaf, Toni K. Choueiri, Eliezer VanAllen, Alexandra Snyder, Robert J. Motzer. Correlation of degree of tumor immune infiltration and insertion-and-deletion (indel) burden with outcome on programmed death 1 (PD1) therapy in advanced renal cell cancer (RCC).. Journal of Clinical Oncology, 2018.

Maxim E Zaslavsky, Jacqueline Buros Novik, Eliza J Chang, Jeffrey E Hammerbacher. Infino: a Bayesian hierarchical model improves estimates of immune infiltration into tumor microenvironment. bioRxiv, 2017.

Alexandra Snyder, Tavi Nathanson, Samuel A. Funt, Arun Ahuja, Jacqueline Buros Novik, Matthew D. Hellmann, Eliza Chang, Bulent Arman Aksoy, Hikmat Al-Ahmadie, Erik Yusko, Marissa Vignali, Sharon Benzeno, Mariel Boyd, Meredith Moran, Gopa Iyer, Harlan S. Robins, Elaine R. Mardis, Taha Merghoub, Jeff Hammerbacher, Jonathan E. Rosenberg, Dean F. Bajorin. Contribution of systemic and somatic factors to clinical response and resistance to PD-L1 blockade in urothelial cancer: An exploratory multi-omic analysis. PLOS Medicine, 2017.

S.A. Melville, J. Buros, A.R. Parrado, B. Vardarajan, M.W. Logue, L. Shen, S.L. Risacher, S. Kim, G. Jun, C. Decarli, K.L. Lunetta, C.T. Baldwin, A.J. Saykin, L.A. Farrer. Multiple loci influencing hippocampal degeneration identified by genome scan. Annals of Neurology, 2012.

M.I. Kamboh, F.Y. Demirci, X. Wang, R.L. Minster, M.M. Carrasquillo, V.S. Pankratz, S.G. Younkin, A.J. Saykin, G. Jun, C. Baldwin, M.W. Logue, J. Buros, L. Farrer, M.A. Pericak-Vance, J.L. Haines, R.A. Sweet, M. Ganguli, E. Feingold, S.T. Dekosky, O.L. Lopez, M.M. Barmada. Genome-wide association study of Alzheimer's disease. Translational Psychiatry, 2012.

G. Coppola, S. Chinnathambi, J.J. Lee, B.A. Dombroski, M.C. Baker, A.I. Soto-ortolaza, S.E. Lee, E. Klein, A.Y. Huang, R. Sears, J.R. Lane, A.M. Karydas, R.O. Kenet, J. Biernat, L. Wang, C.W. Cotman, C.S. Decarli, A.I. Levey, J.M. Ringman, M.F. Mendez, H.C. Chui, I. Le ber, A. Brice, M.K. Lupton, E. Preza, S. Lovestone, J. Powell, N. Graff-radford, R.C. Petersen, B.F. Boeve, C.F. Lippa, E.H. Bigio, I. Mackenzie, E. Finger, A. Kertesz, R.J. Caselli, M. Gearing, J.L. Juncos, B. Ghetti, S. Spina, Y.M. Bordelon, W.W. Tourtellotte, M.P. Frosch, J.P.G. Vonsattel, C. Zarow, T.G. Beach, R.L. Albin, A.P. Lieberman, V.M. Lee, J.Q. Trojanowski, V.M. Van deerlin, T.D. Bird, D.R. Galasko, E. Masliah, C.L. White, J.C. Troncoso, D. Hannequin, A.L. Boxer, M.D. Geschwind, S. Kumar, E. Mandelkow, Z.K. Wszolek, R.J. Uitti, D.W. Dickson, J.L. Haines, R. Mayeux, M.A. Pericak-vance, L.A. Farrer, L.G. Apostolova, S.E. Arnold, C.T. Baldwin, R. Barber, M.M. Barmada, T. Beach, G.W. Beecham, D. Beekly, D.A. Bennett, E.H. Bigio, T.D. Bird, D. Blacker, B.F. Boeve, J.D. Bowen, A. Boxer, J.R. Burke, J. Buros, J.D. Buxbaum, N.J. Cairns, L.B. Cantwell, C. Cao, C.S. Carlson, R.M. Carney, M.M. Carrasquillo, S.L. Carroll, H.C. Chui, D.G. Clark, J. Corneveaux, C.W. Cotman, P.K. Crane, C. Cruchaga, J.L. Cummings, P.L. De Jager, C. DeCarli, S.T. DeKosky, F.Y. Demirci, R. Diaz-Arrastia, M. Dick, D.W. Dickson, B.A. Dombroski, R. Duara, W.G. Ellis, N.N. Ertekin-Taner, D. Evans, K.M. Faber, K.B. Fallon, M.R. Farlow, S. Ferris, T.M. Foroud, M.P. Frosch, D.R. Galasko, P.J. Gallins, M. Ganguli, M. Gearing, D.H. Geschwind, B. Ghetti, J.R. Gilbert, S. Gilman, B. Giordani, J.D. Glass, A.M. Goate, N.R. Graff-Radford, R.C. Green, J.H. Growdon, H. Hakonarson, R.L. Hamilton, J. Hardy, L.E. Harrell, E. Head, L.S. Honig, M.J. Huentelman, C.M. Hulette, B.T. Hyman, G.P. Jarvik, G.A. Jicha, L.-W. Jin, N. Johnson, G. Jun, M.I. Kamboh, J. Karlawish, A. Karydas, J.S.K. Kauwe, J.A. Kaye, R. Kim, E.H. Koo, N.W. Kowall, P. Kramer, W.A. Kukull, J.J. Lah, E.B. Larson, A.I. Levey, A.P. Lieberman, O.L. Lopez, K.L. Lunetta, W.J. Mack, D.C. Marson, E.R. Martin, F. Martiniuk, D.C. Mash, E. Masliah, W.C. McCormick, S.M. McCurry, A.N. McDavid, A.C. McKee, M. Mesulam, B.L. Miller, C.A. Miller, J.W. Miller, T.J. Montine, J.C. Morris, A.J. Myers, A.C. Naj, P. Nowotny, J.E. Parisi, D.P. Perl, E. Peskind, R.C. Petersen, W.W. Poon, H. Potter, J.F. Quinn, A. Raj, R.A. Rajbhandary, M. Raskind, E.M. Reiman, B. Reisberg, C. Reitz, J.M. Ringman, E.D. Roberson, E. Rogaeva, R.N. Rosenberg, M. Sano, A.J. Saykin, J.A. Schneider, L.S. Schneider, W. Seeley, M.L. Shelanski, M.A. Slifer, C.D. Smith, J.A. Sonnen, S. Spina, P.S. George-Hyslop, R.A. Stern, R.E. Tanzi, J.Q. Trojanowski, J.C. Troncoso, D.W. Tsuang, V.M. Van Deerlin, B.N. Vardarajan, H.V. Vinters, J.P. Vonsattel, L.-S. Wang, S. Weintraub, K.A. Welsh-Bohmer, J. Williamson, R.L. Woltjer, S.G. Younkin, O.A. Ross, R. Rademakers, G.D. Schellenberg, B.L. Miller, E. Mandelkow, D.H. Geschwind. Evidence for a role of the rare p.A152T variant in mapt in increasing the risk for FTD-spectrum and Alzheimer's diseases. Human Molecular Genetics, 2012.

G. Jun, B.N. Vardarajan, J. Buros, C.-E. Yu, M.V. Hawk, B.A. Dombroski, P.K. Crane, E.B. Larson, R. Mayeux, J.L. Haines, K.L. Lunetta, M.A. Pericak-Vance, G.D. Schellenberg, L.A. Farrer. Comprehensive search for Alzheimer disease susceptibility loci in the APOE region. Archives of Neurology, 2012.

G. Jun, J.A. Moncaster, C. Koutras, S. Seshadri, J. Buros, A.C. McKee, G. Levesque, P.A. Wolf, P. St. George-Hyslop, L.E. Goldstein, L.A. Farrer. $delta$-Catenin Is Genetically and Biologically Associated with Cortical Cataract and Future Alzheimer-Related Structural and Functional Brain Changes. PLoS ONE, 2012.

G. Jun, M. Nicolaou, M.A. Morrison, J. Buros, D.J. Morgan, M.J. Radeke, Y. Yonekawa, E.E. Tsironi, M.G. Kotoula, F. Zacharaki, N. Mollema, Y. Yuan, J.W. Miller, N.B. Haider, G.S. Hageman, I.K. Kim, D.A. Schaumberg, L.A. Farrer, M.M. DeAngelis. Influence of ROBO1 and RORA on risk of age-related macular degeneration reveals genetically distinct phenotypes in disease pathophysiology. PLoS ONE, 2011.

V. Kunadian, Y.B. Pride, J.L. Buros, L.N. Ciaglo, D.A. Morrow, C.M. Gibson. Coronary flow reserve varies depending upon the location within the artery it is assessed and the TIMI myocardial perfusion grade: A PROTECT TIMI-30 analysis. Journal of Thrombosis and Thrombolysis, 2011.

A.C. Naj, G. Jun, G.W. Beecham, L.-S. Wang, B.N. Vardarajan, J. Buros, P.J. Gallins, J.D. Buxbaum, G.P. Jarvik, P.K. Crane, E.B. Larson, T.D. Bird, B.F. Boeve, N.R. Graff-Radford, P.L. De Jager, D. Evans, J.A. Schneider, M.M. Carrasquillo, N. Ertekin-Taner, S.G. Younkin, C. Cruchaga, J.S.K. Kauwe, P. Nowotny, P. Kramer, J. Hardy, M.J. Huentelman, A.J. Myers, M.M. Barmada, F.Y. Demirci, C.T. Baldwin, R.C. Green, E. Rogaeva, P.S. George-Hyslop, S.E. Arnold, R. Barber, T. Beach, E.H. Bigio, J.D. Bowen, A. Boxer, J.R. Burke, N.J. Cairns, C.S. Carlson, R.M. Carney, S.L. Carroll, H.C. Chui, D.G. Clark, J. Corneveaux, C.W. Cotman, J.L. Cummings, C. Decarli, S.T. Dekosky, R. Diaz-Arrastia, M. Dick, D.W. Dickson, W.G. Ellis, K.M. Faber, K.B. Fallon, M.R. Farlow, S. Ferris, M.P. Frosch, D.R. Galasko, M. Ganguli, M. Gearing, D.H. Geschwind, B. Ghetti, J.R. Gilbert, S. Gilman, B. Giordani, J.D. Glass, J.H. Growdon, R.L. Hamilton, L.E. Harrell, E. Head, L.S. Honig, C.M. Hulette, B.T. Hyman, G.A. Jicha, L.-W. Jin, N. Johnson, J. Karlawish, A. Karydas, J.A. Kaye, R. Kim, E.H. Koo, N.W. Kowall, J.J. Lah, A.I. Levey, A.P. Lieberman, O.L. Lopez, W.J. MacK, D.C. Marson, F. Martiniuk, D.C. Mash, E. Masliah, W.C. McCormick, S.M. McCurry, A.N. McDavid, A.C. McKee, M. Mesulam, B.L. Miller, C.A. Miller, J.W. Miller, J.E. Parisi, D.P. Perl, E. Peskind, R.C. Petersen, W.W. Poon, J.F. Quinn, R.A. Rajbhandary, M. Raskind, B. Reisberg, J.M. Ringman, E.D. Roberson, R.N. Rosenberg, M. Sano, L.S. Schneider, W. Seeley, M.L. Shelanski, M.A. Slifer, C.D. Smith, J.A. Sonnen, S. Spina, R.A. Stern, R.E. Tanzi, J.Q. Trojanowski, J.C. Troncoso, V.M. Van Deerlin, H.V. Vinters, J.P. Vonsattel, S. Weintraub, K.A. Welsh-Bohmer, J. Williamson, R.L. Woltjer, L.B. Cantwell, B.A. Dombroski, D. Beekly, K.L. Lunetta, E.R. Martin, M.I. Kamboh, A.J. Saykin, E.M. Reiman, D.A. Bennett, J.C. Morris, T.J. Montine, A.M. Goate, D. Blacker, D.W. Tsuang, H. Hakonarson, W.A. Kukull, T.M. Foroud, J.L. Haines, R. Mayeux, M.A. Pericak-Vance, L.A. Farrer, G.D. Schellenberg. Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease. Nature Genetics, 2011.

M.W. Logue, M. Schu, B.N. Vardarajan, J. Buros, R.C. Green, R.C.P. Go, P. Griffith, T.O. Obisesan, R. Shatz, A. Borenstein, L.A. Cupples, K.L. Lunetta, D.M. Fallin, C.T. Baldwin, L.A. Farrer. A comprehensive genetic association study of Alzheimer disease in African Americans. Archives of Neurology, 2011.

G. Jun, A.C. Naj, G.W. Beecham, L.-S. Wang, J. Buros, P.J. Gallins, J.D. Buxbaum, N. Ertekin-Taner, M.D. Fallin, R. Friedland, R. Inzelberg, P. Kramer, E. Rogaeva, P. St George-Hyslop, L.B. Cantwell, B.A. Dombroski, A.J. Saykin, E.M. Reiman, D.A. Bennett, J.C. Morris, K.L. Lunetta, E.R. Martin, T.J. Montine, A.M. Goate, D. Blacker, D.W. Tsuang, D. Beekly, L.A. Cupples, H. Hakonarson, W. Kukull, T.M. Foroud, J. Haines, R. Mayeux, L.A. Farrer, M.A. Pericak-Vance, G.D. Schellenberg. Meta-analysis confirms CR1, CLU, and PICALM as Alzheimer disease risk loci and reveals interactions with APOE genotypes. Archives of Neurology, 2010.

V. Kunadian, C. Harrigan, C. Zorkun, A.M. Palmer, K.J. Ogando, L.H. Biller, E.E. Lord, S.P. Williams, M.E. Lew, L.N. Ciaglo, J.L. Buros, S.J. Marble, W.J. Gibson, C.M. Gibson. Use of the TIMI frame count in the assessment of coronary artery blood flow and microvascular function over the past 15 years. Journal of Thrombosis and Thrombolysis, 2009.

V. Kunadian, C. Zorkun, W.J. Gibson, N. Nethala, C. Harrigan, A.M. Palmer, K.J. Ogando, L.H. Biller, E.E. Lord, S.P. Williams, M.E. Lew, L.N. Ciaglo, J.L. Buros, S.J. Marble, C.M. Gibson. Transfusion associated microchimerism: A heretofore little recognized complication following transfusion. Journal of Thrombosis and Thrombolysis, 2009.

C.M. Gibson, Y.B. Pride, J.L. Buros, L.N. Ciaglo, D.A. Morrow, B.M. Scirica, P.H. Stone. Timing and Duration of Myocardial Ischemia on Holter Monitoring Following Percutaneous Coronary Intervention and Their Association With Clinical Outcomes (a PROTECT-TIMI 30 Substudy Analysis). American Journal of Cardiology, 2009.

M.S. Maron, B.J. Maron, C. Harrigan, J. Buros, C.M. Gibson, I. Olivotto, L. Biller, J.R. Lesser, J.E. Udelson, W.J. Manning, E. Appelbaum. Hypertrophic Cardiomyopathy Phenotype Revisited After 50 Years With Cardiovascular Magnetic Resonance. Journal of the American College of Cardiology, 2009.

S.R. Wilson, B.M. Scirica, E. Braunwald, S.A. Murphy, E. Karwatowska-Prokopczuk, J.L. Buros, B.R. Chaitman, D.A. Morrow. Efficacy of Ranolazine in Patients With Chronic Angina. Observations From the Randomized, Double-Blind, Placebo-Controlled MERLIN-TIMI (Metabolic Efficiency With Ranolazine for Less Ischemia in Non-ST-Segment Elevation Acute Coronary Syndromes) 36 Trial. Journal of the American College of Cardiology, 2009.

Y.B. Pride, S.D. Wiviott, J.L. Buros, C. Zorkun, M.U. Tariq, E.M. Antman, E. Braunwald, C.M. Gibson. Effect of prasugrel versus clopidogrel on outcomes among patients with acute coronary syndrome undergoing percutaneous coronary intervention without stent implantation: A TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet inhibitio. American Heart Journal, 2009.

C.M. Gibson, Y.B. Pride, P.E. Aylward, J.J. Col, S.G. Goodman, D. Gulba, M. Bergovec, V. Kunadian, C. Zorkun, J.L. Buros, S.A. Murphy, E.M. Antman. Association of non-steroidal anti-inflammatory drugs with outcomes in patients with ST-segment elevation myocardial infarction treated with fibrinolytic therapy: An ExTRACT-TIMI 25 analysis. Journal of Thrombosis and Thrombolysis, 2009.

C.J. Harrigan, E. Appelbaum, B.J. Maron, J.L. Buros, C.M. Gibson, J.R. Lesser, J.E. Udelson, W.J. Manning, M.S. Maron. Significance of Papillary Muscle Abnormalities Identified by Cardiovascular Magnetic Resonance in Hypertrophic Cardiomyopathy. American Journal of Cardiology, 2008.

A.S. Adabag, B.J. Maron, E. Appelbaum, C.J. Harrigan, J.L. Buros, C.M. Gibson, J.R. Lesser, C.A. Hanna, J.E. Udelson, W.J. Manning, M.S. Maron. Reply. Journal of the American College of Cardiology, 2008.

C.M. Gibson, Y.B. Pride, J.L. Buros, V. Kunadian, M.C. Southard, C.J. Harrigan, L.N. Ciaglo, M.S. Sabatine, C.P. Cannon, E. Braunwald. Relation of Hyperemic Epicardial Flow to Outcomes Among Patients With ST-Segment Elevation Myocardial Infarction Receiving Fibrinolytic Therapy. American Journal of Cardiology, 2008.

A.S. Adabag, B.J. Maron, E. Appelbaum, C.J. Harrigan, J.L. Buros, C.M. Gibson, J.R. Lesser, C.A. Hanna, J.E. Udelson, W.J. Manning, M.S. Maron. Occurrence and Frequency of Arrhythmias in Hypertrophic Cardiomyopathy in Relation to Delayed Enhancement on Cardiovascular Magnetic Resonance. Journal of the American College of Cardiology, 2008.

D.A. Morrow, Y. Wang, K. Croce, M. Sakuma, M.S. Sabatine, H. Gao, A.D. Pradhan, A.M. Healy, J. Buros, C.H. McCabe, P. Libby, C.P. Cannon, E. Braunwald, D.I. Simon. Myeloid-related protein 8/14 and the risk of cardiovascular death or myocardial infarction after an acute coronary syndrome in the Pravastatin or Atorvastatin Evaluation and Infection Theraphy: Thrombolysis in Myocardial Infarction (PROVE IT-TIMI 22) tria. American Heart Journal, 2008.

A. Sabir, C.-S. Yam, N. Yoshimura, J.L. Buros, A.M. De Grand, V. Raptopoulos, M.E. Clouse. Measuring noncalcified coronary atherosclerotic plaque using voxel analysis with MDCT angiography: Phantom validation. American Journal of Roentgenology, 2008.

V. Kunadian, C. Zorkun, S.P. Williams, L.H. Biller, A.M. Palmer, K.J. Ogando, M.E. Lew, N. Nethala, W.J. Gibson, S.J. Marble, J.L. Buros, C.M. Gibson. Intracoronary pharmacotherapy in the management of coronary microvascular dysfunction. Journal of Thrombosis and Thrombolysis, 2008.

S.A. Olenchock Jr., D. Karmpaliotis, W.J. Gibson, S.A. Murphy, M.C. Southard, L. Ciaglo, J. Buros, M.J. Mack, J.H. Alexander, R.A. Harrington, R.M. Califf, N.T. Kouchoukos, T.B. Ferguson Jr., C.M. Gibson. Impact of Saphenous Vein Graft Radiographic Markers on Clinical Events and Angiographic Parameters. Annals of Thoracic Surgery, 2008.

M.S. Maron, E. Appelbaum, C.J. Harrigan, J. Buros, C.M. Gibson, C. Hanna, J.R. Lesser, J.E. Udelson, W.J. Manning, B.J. Maron. Clinical profile and significance of delayed enhancement in hypertrophic cardiomyopathy.. Circulation. Heart failure, 2008.

C.M. Gibson, Y.B. Pride, J.L. Buros, E. Lord, A. Shui, S.A. Murphy, D.S. Pinto, P.J. Zimetbaum, M.S. Sabatine, C.P. Cannon, M.E. Josephson. Association of Impaired Thrombolysis In Myocardial Infarction Myocardial Perfusion Grade With Ventricular Tachycardia and Ventricular Fibrillation Following Fibrinolytic Therapy for ST-Segment Elevation Myocardial Infarction. Journal of the American College of Cardiology, 2008.

Y.B. Pride, J.L. Buros, E. Lord, M.C. Southard, C.J. Harrigan, L.N. Ciaglo, M.S. Sabatine, C.P. Cannon, C.M. Gibson. Angiographic perfusion score in patients treated with PCI at late angiography following fibrinolytic administration for ST-segment elevation myocardial infarction is associated with morbidity and mortality at 30 days. Journal of Thrombosis and Thrombolysis, 2008.

K.K. Ray, C.P. Cannon, D.A. Morrow, A.J. Kirtane, J. Buros, N. Rifai, C.H. McCabe, C.M. Gibson, E. Braunwald. Synergistic relationship between hyperglycaemia and inflammation with respect to clinical outcomes in non-ST-elevation acute coronary syndromes: Analyses from OPUS-TIMI 16 and TACTICS-TIMI 18. European Heart Journal, 2007.

C.M. Gibson, J. Buros, L.N. Ciaglo, M.C. Southard, S. Takao, C. Harrigan, J. Filopei, M. Lew, S.J. Marble, S.A. Murphy, M.G. Cohen. Impact of Iodinated Contrast Injections on Percent Diameter Coronary Arterial Stenosis and Implications for Trials of Intracoronary Pharmacotherapies in Patients With ST-Elevation Myocardial Infarction. American Journal of Cardiology, 2007.

M.P. Bonaca, S.D. Wiviott, M.S. Sabatine, J. Buros, S.A. Murphy, B.M. Scirica, N. Rifai, E.M. Antman, D.A. Morrow. Hemodynamic Significance of Periprocedural Myocardial Injury Assessed With N-Terminal Pro-B-Type Natriuretic Peptide After Percutaneous Coronary Intervention in Patients With Stable and Unstable Coronary Artery Disease (from the JUMBO-TIMI 26 Trial). American Journal of Cardiology, 2007.

B.A. Steinberg, N. Moghbeli, J. Buros, M. Ruda, A. Parkhomenko, B.S. Raju, A. García-Castillo, M. Janion, J.C. Nicolau, K.A.A. Fox, D.A. Morrow, C.M. Gibson, E.M. Antman. Global outcomes of ST-elevation myocardial infarction: Comparisons of the Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis In Myocardial Infarction study 25 (ExTRACT-TIMI 25) registry and trial. American Heart Journal, 2007.

M.C. Gibson, L.N. Ciaglo, M.C. Southard, S. Takao, C. Harrigan, J. Lewis, J. Filopei, M. Lew, S.A. Murphy, J. Buros. Diagnostic and prognostic value of ambulatory ECG (Holter) monitoring in patients with coronary heart disease: A review. Journal of Thrombosis and Thrombolysis, 2007.

C.M. Gibson, H.Q. Ly, S.A. Murphy, L.N. Ciaglo, M.C. Southard, E.B. Stein, J.L. Buros, M.S. Sabatine, C.P. Cannon. Usefulness of Clopidogrel in Abolishing the Increased Risk of Reinfarction Associated With Higher Platelet Counts in Patients With ST-Elevation Myocardial Infarction (Results from CLARITY-TIMI 28). American Journal of Cardiology, 2006.

M. O’Donoghue, J.A. De Lemos, D.A. Morrow, S.A. Murphy, J.L. Buros, C.P. Cannon, M.S. Sabatine. Prognostic utility of heart-type fatty acid binding protein in patients with acute coronary syndromes. Circulation, 2006.

H.Q. Ly, A.J. Kirtane, S.A. Murphy, J. Buros, C.P. Cannon, E. Braunwald, C.M. Gibson. Association of Platelet Counts on Presentation and Clinical Outcomes in ST-Elevation Myocardial Infarction (from the TIMI Trials). American Journal of Cardiology, 2006.

J.L. Januzzi Jr., J. Buros, C.P. Cannon. Peripheral arterial disease, acute coronary syndromes, and early invasive management: The TACTICS TIMI 18 trial. Clinical Cardiology, 2005.

H.Q. Ly, A.J. Kirtane, J. Buros, R.P. Giugliano, J.J. Popma, E.M. Antman, R.A. Harrington, E.M. Ohman, C.M. Gibson. Angiographic and clinical outcomes associated with direct versus conventional stenting among patients treated with fibrinolytic therapy for ST-elevation acute myocardial infarction. American Journal of Cardiology, 2005.

D.S. Pinto, A.J. Kirtane, N.A. Ruocco, A.J. Deibele, A. Shui, J. Buros, S.A. Murphy, C.M. Gibson. Administration of intracoronary Eptifibatide during ST-elevation myocardial infarction. American Journal of Cardiology, 2005.